EIRs Full Text!Click here to search inspection documents FULL TEXT!
Searching is free.
You can already search the descriptions of all of FOI’s records…and now, you can search the full text of EIRs, 483s, FDA/Industry correspondence and other inspection-related content for revealing and hard to find information:
Enter your keyword(s) to search the
The Freedom of Information Act (FOIA) requires U.S. agencies to disclose many of their records. FDA's FOIA records usually aren't on the agency website – they're files from the desk drawers of reviewers, investigators, and other officials - and FOI Services has collected over 100,000 of these documents. Contact us at infoFOI@foiservices.com for more information.
Find a Document You Need?
Add it to your cart and download it immediately.
Want Some Advice?
Contact us...our information specialists can explain document
content, help you search, and answer other questions.
Can't Find Something?
Call us at +1-301-975-9400 to place a custom request.
This week's document is a transcript of remarks made at a November 2017 American Bar Association meeting presented by Maureen Ohlhausen, Acting Chair of the Federal Trade Commission. The speech outlines FTC efforts to comply with the executive order to foster competition in healthcare markets and addresses anticompetitive behavior in markets for patented pharmaceuticals, including pay-for-delay, company court filings which delay FDA approval of competitive products, barriers to market entry for generic drugs, and state initiatives. Links to supporting documentation are provided.
Featured until May 1, 2018. Click here to download.